×

Big Valeant bull dissents

12:19 PM ET Thu, 22 Oct 2015

Valeant is having another rough day after Citron Research called the company's "Specialty Pharmacy" structure into question. Alex Arfaei, does not see fraud right now at the company, but explains why the firm downgraded the stock to market perform.